July 24, 2022 Comments Off on New patent for Gilead Sciences drug VOSEVI Posted in: Patent Added Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPate…
July 23, 2022 Comments Off on New patent for Allergan drug VRAYLAR Posted in: Patent Added Annual Drug Patent Expirations for VRAYLAR Vraylar is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent for Allergan drug VRAYLAR appeared first on DrugPa…